Heart Failure Clinical Trials in Lincoln, Nebraska
5 studies are recruiting for heart failure in Lincoln, Nebraska right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empa…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Velocity Clinical Research-Lincoln-69943, Lincoln, Nebraska
- Locations
- 652 in total
- Run by
- Boehringer Ingelheim
-
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) and excess body weight when compared to placebo. The purpose of this clinical study is to f…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Velocity Clinical Research Lincoln, Lincoln, Nebraska
- Locations
- 838 in total
- Run by
- Novo Nordisk A/S
-
Assessment of CCM in HF With Higher Ejection Fraction
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Bryan Heart, Lincoln, Nebraska
- Locations
- 105 in total
- Run by
- Impulse Dynamics
-
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
The purpose of this study is to learn about the safety and effects of the study medicine (PF-07328948) for the possible treatment of heart failure (HF).
- Stage
- Phase 2
- Ages
- 18 to 79
- Site
- Velocity Clinical Research, Lincoln, Pioneer Heart Institute, Lincoln, Nebraska
- Locations
- 142 in total
- Run by
- Pfizer
-
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.
- Stage
- Not phased
- Ages
- 22 and older
- Site
- Nebraska Heart Center, Lincoln, Nebraska
- Locations
- 45 in total
- Run by
- Cordio Medical
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.